Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00257478 · ClinicalTrials.gov registry record · Phase 2
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
A Phase 2 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00257478 is a Phase 2 study that has completed, run by Astellas Pharma.
The verdict
NCT00257478, a Phase 2 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.
Interventions
- DRUG YM155
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00257478
The ClinicalTrials.gov registry entry for NCT00257478 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which YM155 is the first listed.
NCT00257478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00257478 about?
NCT00257478 is a clinical study titled "A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy". A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.
What is the current status of trial NCT00257478?
This trial is currently completed. It is a Phase 2 study. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00257478?
The interventions under investigation include: YM155 (DRUG).
Who is sponsoring clinical trial NCT00257478?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.